SuperGen Names Mohammad Azab, M.D., Chief Medical Officer
SuperGen Inc. announced the addition of Mohammad Azab, M.D., M Sc, MBA to the management team as Chief Medical Officer. Dr. Azab will manage SuperGen’s clinical development strategy, clinical operations, regulatory affairs, quality, and safety departments to advance the Company’s oncology product portfolio from discovery through clinical Proof of Concept. His responsibilities will include the design and execution of clinical trials, including the recently commenced Phase I study of the first-in-class PIM Kinase Inhibitor, SGI-1776.
With more than 20 years of experience in worldwide drug development, clinical research, and medical affairs, resulting in eight approved drugs, including six in oncology, Dr. Azab brings extensive, international development and translational medicine expertise to SuperGen. Most recently, he was President and CEO of Intradigm Corporation, a privately held Palo Alto, CA company developing siRNA cancer therapeutics. Previously, Dr. Azab served as Executive Vice President of Research and Development, and Chief Medical Officer, of Vancouver, British Columbia-based QLT Inc., where he led clinical development for now-approved drugs in oncology, gastro-intestinal, and ophthalmologic indications. Prior to this, he served as Oncology Drug Team Leader at UK-based Zeneca Pharmaceuticals, now Astra Zeneca, where he held responsibilities in global clinical development and regulatory submissions. In this capacity, he managed the approval of drugs for prostate, breast, colorectal, and lung cancer indications. Before Zeneca, Dr. Azab was an international medical manager in oncology at Sanofi Pharmaceuticals, now Sanofi-Aventis, in Gentilly, France.
Dr. Azab received his medical degree in 1979 from Cairo University. He practiced as a medical oncologist and received post-graduate training and degrees in oncology research and statistics from the University of Paris-Sud and the University of Pierre and Marie Curie in France.
Other news from the department people
